Section Editors

Section Board for 'Infection Prevention and Control' (6)

Please see the section webpage for more information on this section.

Dr. Simon D. Goldenberg
Centre for Clinical Infection and Diagnostics Research, King's College London, and Guy's and St Thomas' NHS Foundation Trust, London SE1 7EH, UK
Interests: healthcare associated infections; clostridium difficile infections; infection prevention and control; decontamination; engineering aspects of infection control and the built environment; antimicrobial resistance; laboratory diagnostics (including molecular and point of care)
Dr. Pierre Magal
Institut de Mathématiques de Bordeaux,Université de Bordeaux, 351 cours de la libération, 33400 Talence, France
Interests: infectious disease outbreaks; differential equations; dynamical systems and mathematical biology
Special Issues, Collections and Topics in MDPI journals
Dr. Joan Puig-Barberà
Vaccines Research Area FISABIO, 46020 Valencia, Spain
Interests: hospitalization; influenza; human, vaccination; community-acquired infections; epidemiology; immunology, virology; prevention & control; respiratory syncytial viruses; population surveillance; reverse transcriptase polymerase chain reaction
Special Issues, Collections and Topics in MDPI journals
Dr. George Rachiotis
Department of Hygiene and Epidemiology, Medical Faculty, University of Thessaly, Larissa 41222, Greece
Interests: epidemiology; occupational medicine; social determinants of health
Special Issues, Collections and Topics in MDPI journals
Prof. Dr. Frederic Schoenberg
Department of Statistics, University of California Los Angeles, Los Angeles, CA 90095-1554, USA
Interests: Covid-19; Ebola; spread of infectious diseases; Hawkes point process models
Dr. Timothy J. Wade
USA Environmental Protection Agency (EPA), Office of Research and Development, National Health and Environmental Effects Research Laboratory, Environmental Public Health Division, Research Triangle Park, NC 27709, USA
Interests: environmental epidemiology; waterborne disease; infectious disease; microbial risk assessment
Back to TopTop